Records containing: Thyroid Cancer
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-27Phase 1/2, Open-Label Study of the Safety, Dosimetry and Efficacy of a 3-Dose Regimen of Escalating Doses of 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2026-04-27Outcomes of Patients With Thyroid Carcinoma Treated With Redifferentiating Agents as Part of Routine Clinical Care: A Prospective Data Collection Study
-
CLINICAL_TRIALS study record update · 2026-04-24Phase 1/2, Open-Label Study of the Safety, Dosimetry and Efficacy of a 3-Dose Regimen of Escalating Doses of 177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2026-04-24Neoadjuvant Treatment With Zanzalintinib for Advanced Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2026-04-23A PHASE 1, OPEN-LABEL, DOSE ESCALATION AND DOSE EXPANSION STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND ANTI TUMOR ACTIVITY OF PF-07799933 (ARRY-440) AS A SINGLE AGENT AND IN COMBINATION THERAPY IN PARTICIPANTS 16 YEARS AND OLDER WITH ADVANCED SOLID TUMORS WITH BRAF ALTERATIONS
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-23A PHASE 1A/B OPEN-LABEL MASTER STUDY OF PF-07799544 AS A SINGLE-AGENT AND IN COMBINATION WITH OTHER TARGETED AGENTS IN PARTICIPANTS WITH BRAF-MUTANT MELANOMA AND OTHER SOLID TUMORS
-
CLINICAL_TRIALS study record update · 2026-04-22Selpercatinib and Body Composition
-
CLINICAL_TRIALS study record update · 2026-04-22Comparison of I-124 PET/CT to I-123 Whole Body Imaging for the Diagnosis of Thyroid
-
CLINICAL_TRIALS study record update · 2026-04-21A Phase 1/2, Open-label Study of Oral S241656 (BDTX-4933) as Monotherapy and in Combination With Other Anti-Cancer Therapies in Patients With KRAS, BRAF and Other Selected RAS/MAPK Mutation-Positive Malignancies
-
CLINICAL_TRIALS study record update · 2026-04-21Mortality Benefit of Ultrasound for Incidental Thyroid Nodules Identified With PET Imaging: A Non-Inferiority Emulated Target Trial
-
CLINICAL_TRIALS study record update · 2026-04-20The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2026-04-20Studies on Thyroid Nodules and Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2026-04-20ImmunoPET Targeting Trophoblast Cell-Surface Antigen 2 (Trop-2) in Thyroid Cancer and Compared With 18F-FDG
-
CLINICAL_TRIALS study record update · 2026-04-20Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk Stratification and Post-Treatment Surveillance in Fresh Thyroid Cancer Patients
-
CLINICAL_TRIALS study record update · 2026-04-17Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2026-04-16Pharmacodynamic Study of Vemurafenib in the Neoadjuvant Setting in Patients With Locally Advanced Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2026-04-15Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
-
CLINICAL_TRIALS study record update · 2026-04-14Trial of Meaning Centered Psychotherapy for Mexican Patients With Advanced Cancer
-
CLINICAL_TRIALS study record update · 2026-04-14Quantitative Imaging Tools to Derive DW-MRI Oncological Biomarkers
-
CLINICAL_TRIALS study record update · 2026-04-13Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2026-04-13Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Well-differentiated Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2026-04-13Targeting the Gut-Brain Axis With Ganoderma Lucidum Spores Ameliorates Depression in Thyroid Cancer Patients: a Randomized, Double-blind, Placebo-controlled Trial
-
CLINICAL_TRIALS study record update · 2026-03-31Effectiveness of T-DXd Across HER2-positive Solid Tumors in Patients Who Have Received Prior Systemic Treatment and Have no Satisfactory Alternative Treatment Options: A Hybrid Observational Study
-
CLINICAL_TRIALS study record update · 2026-03-30A Prospective Multi-centered Observational Study on Postoperative Symptoms After Thyroidectomy (POS-T) in Patients With Thyroid Cancer
-
CLINICAL_TRIALS study record update · 2026-03-27Phase II of Avutometinib (VS-6766) and Defactinib In RAF Dimer-Driven RAI-Refractory Differentiated and Anaplastic Thyroid Cancer Patients